Skip to main content

Surveillance of tuberculosis treatment outcomes of Singapore citizens and permanent residents, 2002–2011

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: Singapore, which had a tuberculosis (TB) incidence rate of 41 per 100 000 resident population in 2011.

OBJECTIVE: To report the outcomes of Singapore citizens and permanent residents treated for TB from 2002 to 2011.

METHODS: A computerised treatment surveillance module (TSM) was launched in 2001 to track the progress and outcome of TB patients nationally. Physicians were required to submit an electronic or paper return for every patient at each clinic visit. Treatment adherence, drugs prescribed, treatment delivery mode and final outcome, specified as ‘completed treatment’, ‘lost to follow-up’, ‘death’, ‘transferred out’, ‘permanent cessation of treatment’ and ‘still on treatment/no final outcome’, were captured. Quarterly cohort outcomes at 12–15 months after starting treatment were combined to generate annual treatment outcomes.

RESULTS: Treatment completion rates increased from 73.4% to 82.8%. The proportion of patients lost to follow-up decreased from 3.4% to 1.7%, while that of patients still on treatment or with no final outcome decreased from 10.5% to 4.4%. The death rate ranged between 10.2% and 11.7%; the majority were not attributed to TB.

CONCLUSION: TB treatment completion among Singapore citizens and permanent residents has improved since 2002 as the likely result of the TSM and other initiatives introduced over the past decade.

Keywords: DOT; death; default; treatment completion

Document Type: Research Article

Affiliations: 1: Singapore Tuberculosis Control Unit, Ministry of Health, Singapore 2: Communicable Diseases Division, Ministry of Health, Singapore

Publication date: 01 February 2014

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content